Glass Lewis Tells Shareholders To Vote Against Elon Musk’s Proposed $56 Billion Compensation Package
Ahead of Tesla Inc's (NASDAQ: TSLA) annual meeting, a major proxy advisory firm recommended that shareholders vote against CEO Elon Musk
Donald Trump To Get Endorsement From Blackstone CEO Steve Schwarzman: Report
Blackstone CEO Steve Schwarzman reportedly pledges to back Donald Trump, signaling a resurgence of support from major donors.
Warren Buffett Disciple Pabrai Retains His Mentor’s Stance On Bitcoin Despite Rally: ‘Going To End Badly’
Amid the volatile waves of the cryptocurrency market, Mohnish Pabrai, an investment fund manager often likened to Warren Buffett, has cast a shadow of doubt over the future of Bitcoin.
Toast Is a Dominant Player With Impressive Momentum, Says Analyst
Wedbush analyst Moshe Katri initiated coverage on Toast with an outperform rating and a $30 price target. Toast reported Q1 revenue of $1.075 billion, surpassing estimates. For 2024, adjusted EBITDA is expected between $250 million and $270 million. The analyst highlighted Toast's robust U.S. SMB pipeline and international market traction, projecting over 30% Y/Y growth in gross profit and EBITDA for FY24 and FY25.
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
The potential rescheduling of cannabis in the U.S.
Magnite Shows Strength With Netflix Partnership, Analyst Expects $30M Revenue By 2025
Magnite could generate $44 million/$69 million/$199 million in revenue in 2026, 2027 and 2028 — all thanks to Netflix.
NASA Confirms Boeing’s Delayed Starliner Launch Despite Helium Leak
Boeing and NASA prepare for the Starliner Crew Flight Test despite a stable helium leak in the propulsion system. Targeting a June 1 launch, this mission will be the first to carry U.S. astronauts.
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
Eli Lilly has significantly increased its investment in its Lebanon, Indiana, manufacturing site to $9 billion, aiming to enhance production of tirzepatide injections.
CVS Health Seeks Private Equity Partner for Oak Street Health Expansion
CVS Health seeks a private equity partner to fund the expansion of Oak Street Health, acquired for $10.6 billion. This joint venture aims to open new clinics, easing initial losses and protecting CVS's financial health.
Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit
Chicago jury rejects woman's claim that Zantac caused her colon cancer. First of thousands of similar lawsuits, companies deny scientific evidence.